| 1939 |
1635: Increase, DNA strand breaks |
1636: Increase, Chromosomal aberrations |
Jun 3, 2019 |
Jan 9, 2023 |
2 AOPs
|
| 2074 |
1635: Increase, DNA strand breaks |
1365: Increase, Apoptosis |
Apr 6, 2020 |
Apr 6, 2020 |
1 AOP
|
| 2587 |
1635: Increase, DNA strand breaks |
1444: Increase, Follicular atresia |
Mar 1, 2022 |
Mar 1, 2022 |
1 AOP
|
| 2589 |
1635: Increase, DNA strand breaks |
1775: Increase, Oocyte apoptosis |
Mar 1, 2022 |
Mar 1, 2022 |
1 AOP
|
| 2841 |
1635: Increase, DNA strand breaks |
2098: Abnormal Neural Remodeling |
Jan 25, 2023 |
Jul 29, 2024 |
1 AOP
|
| 2856 |
1635: Increase, DNA strand breaks |
2066: Altered Signaling |
Mar 10, 2023 |
Mar 21, 2023 |
None
|
| 3315 |
1635: Increase, DNA strand breaks |
2244: Altered Stress Response Signaling |
Jul 24, 2024 |
Aug 26, 2024 |
2 AOPs
|
| 3480 |
1635: Increase, DNA strand breaks |
1505: Cell cycle, disrupted |
Jan 20, 2025 |
Jan 20, 2025 |
1 AOP
|
| 3593 |
1635: Increase, DNA strand breaks |
1281: Increased, DNA Damage-Repair |
Aug 16, 2025 |
Aug 16, 2025 |
1 AOP
|
| 732 |
746: Increase, Dopaminergic activity |
747: Decreased, Prolactin |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 770 |
746: Increase, Dopaminergic activity |
773: Increase, Endometrial adenocarcinomas |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 3642 |
2374: Increase, EcR antagonism |
2375: Decrease, Mis-timed EcR-responsive NR cascade |
Sep 29, 2025 |
Sep 29, 2025 |
2 AOPs
|
| 116 |
103: Increase, EcR hyperactivation |
60: Induction, Chitin degradation and resorption |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 998 |
103: Increase, EcR hyperactivation |
988: Decrease, Circulating ETH |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 999 |
103: Increase, EcR hyperactivation |
989: Decreased, synthesis and secretion of molting fluid proteases |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 1007 |
103: Increase, EcR hyperactivation |
994: Decreased, Synthesis of molting fluid proteases |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 1343 |
103: Increase, EcR hyperactivation |
1264: Increase, E75b expression |
Feb 9, 2017 |
Feb 9, 2017 |
1 AOP
|
| 3640 |
103: Increase, EcR hyperactivation |
2373: Increase, Mis-timed EcR-responsive NR cascade |
Sep 29, 2025 |
Sep 29, 2025 |
1 AOP
|
| 2778 |
2068: Increase, Endothelial Dysfunction |
2003: Vascular remodeling |
Sep 28, 2022 |
Sep 28, 2022 |
None
|
| 2784 |
2068: Increase, Endothelial Dysfunction |
2069: Occurrence, Abnormal Vascular Remodeling |
Oct 17, 2022 |
Aug 26, 2024 |
1 AOP
|
| 3373 |
2068: Increase, Endothelial Dysfunction |
901: Infiltration, Inflammatory cells |
Oct 30, 2024 |
Oct 30, 2024 |
1 AOP
|
| 567 |
573: Increase, Energetic demands and therefore metabolic stress |
574: Increased, Appetite and hunger |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 2330 |
1860: Excitation of intracellular water |
1632: Increase in RONS |
Apr 11, 2021 |
Apr 11, 2021 |
None
|
| 132 |
115: Increase, FA Influx |
291: Accumulation, Triglyceride |
Nov 29, 2016 |
Mar 29, 2024 |
2 AOPs
|
| 3546 |
2333: Increase, Fat mass |
2335: Increase, BMI |
Jul 25, 2025 |
Jul 25, 2025 |
1 AOP
|